MolecuLight secures $4 mln in funding round led by iGan Partners
MolecuLight Inc, developer of a handheld optical imaging platform for point-of-care wound analysis and treatment guidance, has secured $4 million in financing. The round was led by Canadian venture capital firm iGan Partners with the participation of a number of angel investors. Founded by Ralph DaCosta, a molecular imaging scientist at the University Health Network, MolecuLight is based in Toronto. The company plans to use investment proceeds to obtain regulatory approvals in the United States, Canada and Europe, complete key hires and prepare products for full commercialization.
30 May 2014•3 mins read
